Area of expertise
Specialty
Hematology, Oncology
Subspecialty
Hematologic Oncology, Medical Oncology
Diseases
Lymphoma, Hematologic Cancers
Procedures Performed
Immunotherapy
Chemotherapy
Adoptive Cell Therapy
Experience
Deputy Director, Division of Onco-Hematological Medicine, Department of Onco-Hematology, San Raffaele Hospital
Milan, Italy. From 2011
Director, Lymphoma Unit, Department of Onco-Hematology, San Raffaele Hospital
Milan, Italy. From 2008
Deputy Director, Medical Oncology Unit, Department of Oncology, San Raffaele Hospital
Milan, Italy. 2007 - 2010
Unit Coordinator, Medical Oncology Unit, San Raffaele Hospital
Milan, Italy. 2004 - 2007
Researcher, Division of Radio-chemotherapy, San Raffaele Hospital
Milan, Italy. 1998 - 2004
Education
MD: University of Buenos Aires
1985
Biography
Dr. Andrés José María Ferreri has an impressive work history and scientific expertise in the field of oncology, specifically focusing on lymphomas. His career began with specialized training in clinical oncology at the Central Military Hospital in Buenos Aires, Argentina, from 1987 to 1989. He then pursued further education and training opportunities abroad, including a fellowship at the National Cancer Institute in Milan, Italy, from 1990 to 1994, where he specialized in experimental oncology a
Affiliations
Member, Global Outreach Committee, European Hematology Association
President, Italian Lymphoma Foundation
Member, Scientific Working Group on Lymphomas, European Hematology Association
Member of the Faculty, College of the European School of Oncology
Member of the Presidency Office, Italian Lymphoma Foundation
Awards
Recognized as a “World Expert in Lymphoma”. Placed in the top 0.1% of scholars writing about Lymphoma based on 53.807 papers. Ranking position: 9° over 129.972 experts (2020, 2021)
Best Paper Award 2015 of the San Raffaele Scientific Institute: “High doses of antimetabolites followed by high-dose sequential chemoimmunotherapy and autologous stem cell transplantation in patients with systemic B-cell lymphoma and secondary central nervous system involvement: final results of a multicenter phase II trial”. Ferreri AJM, Donadoni G, Cabras MG, et al. Journal of Clinical Oncology
2015
Best Paper Award 2010 of the San Raffaele Scientific Institute: “High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial. Ferreri AJ, Reni M, Foppoli M, et al.
2010
International award “Paul Harris Fellow” of the Rotary International Foundation
Publications
Dr. Andrés José María Ferreri has more than 560 publications